BalticVC

Cleveron , the Estonian manufacturer of parcel machines and other robotic solutions, is to lay off 20 employees in Estonia. At the same time, the company will open new local sales offices in key European markets. According to the technology company, it focuses on profitable growth and customer satisfaction now.

Estonian risk management platform Complok  has raised €50K in a convertible loan from Swiss-based Tenity Incubation Fund II. The actual terms and conditions of the convertible loan agreement will be disclosed after the closing of the equity round. Complok has also received an offer from Tenity for a potential follow-on investment of up to €250K. 

Estonian energy producer Sunly has raised €300M in debt financing through the REDI HR2 fund from lead investor Rivage Investment, a Paris-based asset management firm. Copenhagen Infrastructure Partners (CIP) and Norwegian pension company KLP also participated in the deal.

Latvian car-sharing provider Carguru   has acquired Riga-based electric car rental startup OX Drive .

Estonian Trind VC has invested in a Helsinki-based AI-powered platform for recruiters and candidates Jobilla . The €6M round was backed by Finnish VC Juuri Partners, Finnish government organization Business Finland, and Swedish business angel Matti Vikkula. ​​Matti Vikkula will join Jobilla as chairman of the board.

Latvian ZGI Capital has exited from the Riga-based mobile payment system Mobilly , in which it previously held a 9.17% stake. Other shareholders such as Riga-based bank Citadele (owned 12.5%), Latvian charity and support fund Vitolu Fund (3.18%), Uldis Paberzis (20.32%), and Girts Slavins (4.7%) also sold their shares. The amount of the deal was not disclosed.

Better Medicine , a developer of cancer diagnostic solutions, has sold its stake in the company to UniTartu Ventures (the holding company of the University of Tartu) in exchange for intellectual property. Over the next two years, the University of Tartu will transfer the intellectual property created during research and development to Better Medicine.